Comparative Effectiveness of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in Older Nursing Home Residents After Myocardial Infarction: A Retrospective Cohort Study.
Andrew R ZulloMelissa R RiesterSebhat ErqouWen-Chih WuJames L RudolphMichael A SteinmanPublished in: Drugs & aging (2021)
Our findings align with prior data and suggest that clinicians can prescribe either ARBs or ACEIs post-AMI for secondary prevention in NH residents, although the subgroup findings merit further scrutiny and replication. Providers should consider factors such as patient preferences, class-specific adverse events, and costs when prescribing.
Keyphrases
- angiotensin converting enzyme
- angiotensin ii
- vascular smooth muscle cells
- primary care
- acute myocardial infarction
- palliative care
- physical activity
- electronic health record
- room temperature
- randomized controlled trial
- clinical trial
- middle aged
- emergency department
- phase iii
- adverse drug
- percutaneous coronary intervention
- data analysis
- deep learning
- coronary artery disease
- drug induced